Detalhe da pesquisa
1.
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial.
J Intern Med
; 292(6): 925-940, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35934913